Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	KRT5 KRT6A EVPL KRT6C PKP2 PLEC	1.84e-05	99	114	6	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament-based process	KRT5 KRT6A EVPL KRT6C PKP2 PLEC	1.95e-05	100	114	6	GO:0045103
GeneOntologyCellularComponent	intermediate filament	KRT5 KRT6A NCKIPSD EVPL KRT6C PKP2 PLEC	2.93e-04	227	117	7	GO:0005882
GeneOntologyCellularComponent	phosphorylase kinase complex	PHKA1 PHKA2	3.07e-04	5	117	2	GO:0005964
GeneOntologyCellularComponent	protein kinase complex	ERCC2 CEACAM5 INSRR CCNG2 PHKA1 PHKA2	3.93e-04	170	117	6	GO:1902911
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	CUL3 KNTC1 KRT5 KRT6A NCKIPSD TRIM54 EVPL KRT6C PDE4DIP TRIM55 TRIM63 PKP2 PLEC DNAH11	5.03e-04	899	117	14	GO:0099513
HumanPheno	Stratum basale cleavage	KRT5 ITGB4 PLEC	1.18e-06	4	35	3	HP:0034193
HumanPheno	Skin fragility with non-scarring blistering	KRT5 ITGB4 PLEC	1.18e-06	4	35	3	HP:0007585
HumanPheno	Intra-epidermal blistering	KRT5 ITGB4 PLEC	5.86e-06	6	35	3	HP:0033802
HumanPheno	Aplasia cutis congenita on trunk or limbs	KRT5 ITGB4 PLEC	5.86e-06	6	35	3	HP:0007589
HumanPheno	Acral blistering	KRT5 ITGB4 PLEC	2.43e-05	9	35	3	HP:0031045
HumanPheno	Blistering by anatomical location	KRT5 KRT6A ITGB4 PLEC	2.51e-05	26	35	4	HP:0033800
HumanPheno	Abnormal dermatological laboratory findings	KRT5 ITGB4 PLEC	3.45e-05	10	35	3	HP:0003340
HumanPheno	Lamina lucida cleavage	KRT5 ITGB4 PLEC	3.45e-05	10	35	3	HP:0003341
HumanPheno	Onychogryposis	KRT5 KRT6A ITGB4 PLEC	3.93e-05	29	35	4	HP:0001805
HumanPheno	Palmoplantar blistering	KRT5 KRT6A PLEC	4.72e-05	11	35	3	HP:0007446
HumanPheno	Subepidermal blistering	KRT5 ITGB4 PLEC	4.72e-05	11	35	3	HP:0033804
HumanPheno	Blistering by histological location	KRT5 ITGB4 PLEC	8.11e-05	13	35	3	HP:0033801
HumanPheno	Oral mucosal blisters	KRT5 ITGB4 PLEC	1.03e-04	14	35	3	HP:0200097
HumanPheno	Congenital pyloric atresia	ITGB4 PLEC	1.37e-04	3	35	2	HP:0004399
HumanPheno	Milia	KRT5 ITGB4 PLEC	1.89e-04	17	35	3	HP:0001056
HumanPheno	Pregnancy history	ITGB4 ABCB4 DNAAF3 PLEC NOS3 CCDC40 DNAH11	1.91e-04	182	35	7	HP:0002686
HumanPheno	Past medical history	ITGB4 ABCB4 DNAAF3 PLEC NOS3 CCDC40 DNAH11	1.97e-04	183	35	7	HP:0032443
HumanPheno	Abnormal axonemal organization of respiratory motile cilia	CCDC40 DNAH11	2.73e-04	4	35	2	HP:0012258
HumanPheno	Progressive microcephaly	PCLO IQSEC2 SMPD4 CC2D1A VPS53	3.46e-04	91	35	5	HP:0000253
HumanPheno	Aplasia of the bladder	ITGB4 PLEC	4.53e-04	5	35	2	HP:0010477
HumanPheno	Elevated maternal circulating alpha-fetoprotein concentration	ITGB4 PLEC	4.53e-04	5	35	2	HP:0011432
Domain	DUF3669_Znf	ZNF212 ZNF783 ZNF746 ZNF398 ZNF282	4.23e-11	6	112	5	IPR022137
Domain	DUF3669	ZNF212 ZNF783 ZNF746 ZNF398 ZNF282	4.23e-11	6	112	5	PF12417
Domain	COS	TRIM54 TRIM67 TRIM55 TRIM63	5.84e-07	12	112	4	PS51262
Domain	COS_domain	TRIM54 TRIM67 TRIM55 TRIM63	5.84e-07	12	112	4	IPR017903
Domain	Angiomotin	AMOTL1 AMOTL2	1.07e-04	3	112	2	IPR009114
Domain	Glyco_hydro_15/PHK	PHKA1 PHKA2	1.07e-04	3	112	2	IPR011613
Domain	PHK_A/B_su	PHKA1 PHKA2	1.07e-04	3	112	2	IPR008734
Domain	Glyco_hydro_15	PHKA1 PHKA2	1.07e-04	3	112	2	PF00723
Domain	Angiomotin_C	AMOTL1 AMOTL2	1.07e-04	3	112	2	IPR024646
Domain	Angiomotin_C	AMOTL1 AMOTL2	1.07e-04	3	112	2	PF12240
Domain	Keratin_2_head	KRT5 KRT6A KRT6C	3.88e-04	24	112	3	IPR032444
Domain	Keratin_2_head	KRT5 KRT6A KRT6C	3.88e-04	24	112	3	PF16208
Domain	Keratin_II	KRT5 KRT6A KRT6C	4.94e-04	26	112	3	IPR003054
Domain	-	EVPL PLEC	5.26e-04	6	112	2	3.90.1290.10
Domain	Spectrin_repeat	EVPL SPTBN5 PLEC	6.85e-04	29	112	3	IPR002017
Domain	Plectin	EVPL PLEC	7.34e-04	7	112	2	PF00681
Domain	Plectin_repeat	EVPL PLEC	7.34e-04	7	112	2	IPR001101
Domain	PLEC	EVPL PLEC	7.34e-04	7	112	2	SM00250
Domain	BBOX	TRIM54 TRIM67 TRIM55 TRIM63	7.85e-04	69	112	4	SM00336
Domain	-	TRIM54 TRIM67 TRIM55 TRIM63	8.74e-04	71	112	4	4.10.45.10
Domain	SPEC	EVPL SPTBN5 PLEC	9.17e-04	32	112	3	SM00150
Domain	Spectrin/alpha-actinin	EVPL SPTBN5 PLEC	9.17e-04	32	112	3	IPR018159
Domain	zf-B_box	TRIM54 TRIM67 TRIM55 TRIM63	9.21e-04	72	112	4	PF00643
Domain	6hp_glycosidase	PHKA1 PHKA2	9.75e-04	8	112	2	IPR012341
Domain	Chond_GalNAc	CSGALNACT2 B4GALNT3	9.75e-04	8	112	2	IPR008428
Domain	CHGN	CSGALNACT2 B4GALNT3	9.75e-04	8	112	2	PF05679
Domain	-	PHKA1 PHKA2	9.75e-04	8	112	2	1.50.10.10
Domain	AB_hydrolase_1	ABHD14A ABHD16B ABHD13	1.00e-03	33	112	3	IPR000073
Domain	zf-RING_UBOX	TRIM54 TRIM55 TRIM63	1.10e-03	34	112	3	PF13445
Domain	Znf-RING_LisH	TRIM54 TRIM55 TRIM63	1.10e-03	34	112	3	IPR027370
Domain	Hydrolase_4	ABHD14A ABHD13	1.25e-03	9	112	2	IPR022742
Domain	Hydrolase_4	ABHD14A ABHD13	1.25e-03	9	112	2	PF12146
Domain	FN3	VASN INSRR MDGA2 ITGB4 FNDC1 TRIM67	1.27e-03	199	112	6	PS50853
Domain	ZF_BBOX	TRIM54 TRIM67 TRIM55 TRIM63	1.37e-03	80	112	4	PS50119
Domain	Znf_B-box	TRIM54 TRIM67 TRIM55 TRIM63	1.43e-03	81	112	4	IPR000315
Domain	FN3_dom	VASN INSRR MDGA2 ITGB4 FNDC1 TRIM67	1.63e-03	209	112	6	IPR003961
Domain	t-SNARE	KRT6A ZNF746 AMOTL2	2.18e-03	43	112	3	IPR010989
Domain	6-hairpin_glycosidase-like	PHKA1 PHKA2	2.66e-03	13	112	2	IPR008928
Domain	fn3	VASN INSRR ITGB4 FNDC1 TRIM67	2.94e-03	162	112	5	PF00041
Domain	PH_dom-like	ARHGAP26 IQSEC2 VPS36 PTPN21 ARHGEF25 SPTBN5 LRBA RASAL1	4.14e-03	426	112	8	IPR011993
Domain	FN3	VASN INSRR ITGB4 FNDC1 TRIM67	5.16e-03	185	112	5	SM00060
Domain	Fd_Rdtase_FAD-bd	DUOX1 NOS3	5.70e-03	19	112	2	IPR017927
Domain	FAD_FR	DUOX1 NOS3	5.70e-03	19	112	2	PS51384
Domain	Riboflavin_synthase-like_b-brl	DUOX1 NOS3	5.70e-03	19	112	2	IPR017938
Pathway	REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY	KRT5 ITGB4 PLEC	1.92e-05	9	88	3	MM15117
Pathway	REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY	KRT5 ITGB4 PLEC	3.74e-05	11	88	3	M27372
Pubmed	Cytoplasmic plaque formation in hemidesmosome development is dependent on SoxF transcription factor function.	KRT5 VWF ITGB4 PLEC	9.10e-08	13	119	4	22962592
Pubmed	Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain.	TRIM54 TRIM55 TRIM63	1.56e-07	4	119	3	11243782
Pubmed	E3-ligase knock down revealed differential titin degradation by autopagy and the ubiquitin proteasome system.	TRIM54 TRIM55 TRIM63	7.75e-07	6	119	3	34702928
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	CUL3 RANBP10 RNF25 CHD9 PHKA1 PHKA2 STRN PDE4DIP	1.07e-06	223	119	8	33187986
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCC3 RANBP10 ERCC2 PIEZO1 ARHGAP26 FRMD8 CC2D1A IRF5 SFI1 ITGB4 ZNF398 PLEC LRBA TTC38 RASAL1 BAHCC1	1.21e-06	1105	119	16	35748872
Pubmed	Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1.	TRIM54 TRIM55 TRIM63	1.35e-06	7	119	3	11927605
Pubmed	Developmental regulation of MURF ubiquitin ligases and autophagy proteins nbr1, p62/SQSTM1 and LC3 during cardiac myofibril assembly and turnover.	TRIM54 TRIM55 TRIM63	3.23e-06	9	119	3	21185285
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	VGF CUL3 RANBP10 IQSEC2 JAKMIP3 STRN TRIM67 PDE4DIP ELAVL4 TNKS SSH2 PCDH8 RASAL1 TP53BP1	5.67e-06	963	119	14	28671696
Pubmed	Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth.	AMOTL1 PKP2 AMOTL2	6.32e-06	11	119	3	28239148
Pubmed	Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus.	KRT5 ITGB4 PLEC	6.32e-06	11	119	3	12802069
Pubmed	Current insights into the formation and breakdown of hemidesmosomes.	KRT5 ITGB4 PLEC	6.32e-06	11	119	3	16757171
Pubmed	Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA.	KRT5 KRT6A ITGB4	8.40e-06	12	119	3	14610062
Pubmed	p63 Transcription Factor Regulates Nuclear Shape and Expression of Nuclear Envelope-Associated Genes in Epidermal Keratinocytes.	SUN1 ITGB4 PLEC	8.40e-06	12	119	3	28595999
Pubmed	Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin beta4 cytoplasmic domain.	KRT5 ITGB4 PLEC	1.09e-05	13	119	3	9670011
Pubmed	The multiphosphorylation domain of the phosphorylase kinase alpha M and alpha L subunits is a hotspot of differential mRNA processing and of molecular evolution.	PHKA1 PHKA2	1.16e-05	2	119	2	8226841
Pubmed	Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the beta 4 integrin gene (ITGB4) and genotype/phenotype correlations.	ITGB4 PLEC	1.16e-05	2	119	2	11328943
Pubmed	Placental expression of striatin & endothelial nitric oxide synthase in women with & without pre-eclampsia.	STRN NOS3	1.16e-05	2	119	2	37147942
Pubmed	Modeling and experimental validation of the binary complex of the plectin actin-binding domain and the first pair of fibronectin type III (FNIII) domains of the beta4 integrin.	ITGB4 PLEC	1.16e-05	2	119	2	15817481
Pubmed	Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney.	VWF NOS3	1.16e-05	2	119	2	20363914
Pubmed	Mammary mechanobiology - investigating roles for mechanically activated ion channels in lactation and involution.	KRT5 PIEZO1	1.16e-05	2	119	2	33262312
Pubmed	X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase.	PHKA1 PHKA2	1.16e-05	2	119	2	8733133
Pubmed	Cytokeratin 5/6 expression in pT1 bladder cancer predicts intravesical recurrence in patients treated with bacillus Calmette-Guérin instillation.	KRT5 KRT6A	1.16e-05	2	119	2	35527047
Pubmed	Widespread aplasia cutis congenita in sibs with PLEC1 and ITGB4 variants.	ITGB4 PLEC	1.16e-05	2	119	2	31184804
Pubmed	KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2.	ERCC2 KIAA1549	1.16e-05	2	119	2	37140813
Pubmed	cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis.	PHKA1 PHKA2	1.16e-05	2	119	2	1372435
Pubmed	Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model.	TRIM55 TRIM63	1.16e-05	2	119	2	32340625
Pubmed	Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.	KRT6A KRT6C	1.16e-05	2	119	2	23662636
Pubmed	Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo.	TRIM55 TRIM63	1.16e-05	2	119	2	23512667
Pubmed	New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations.	TRIM54 TRIM63	1.16e-05	2	119	2	25801283
Pubmed	Muscle RING-finger 2 and 3 maintain striated-muscle structure and function.	TRIM54 TRIM55	1.16e-05	2	119	2	27493870
Pubmed	Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo.	TRIM55 TRIM63	1.16e-05	2	119	2	17272810
Pubmed	Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma.	KRT5 KRT6A	1.16e-05	2	119	2	33435173
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CUL3 ZNF212 PIEZO1 ARHGAP26 SUN1 KIAA1549 SMPD4 SFI1 CEMIP2 AMOTL2	1.47e-05	529	119	10	14621295
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	KNTC1 CCP110 NCKIPSD KIAA1549 NEK4 STRN AMOTL1 PKP2 AMOTL2	2.41e-05	446	119	9	24255178
Pubmed	Genetic variants in pachyonychia congenita-associated keratins increase susceptibility to tooth decay.	KRT6A KRT6C	3.47e-05	3	119	2	29357356
Pubmed	Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins.	KRT5 KRT6A	3.47e-05	3	119	2	7525601
Pubmed	Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.	KRT5 KRT6A	3.47e-05	3	119	2	29587848
Pubmed	Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis.	TRIM54 TRIM63	3.47e-05	3	119	2	18222470
Pubmed	Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein.	TRIM55 TRIM63	3.47e-05	3	119	2	12414993
Pubmed	Differential expression of the motin family in the peri-implantation mouse uterus and their hormonal regulation.	AMOTL1 AMOTL2	3.47e-05	3	119	2	22813598
Pubmed	Comparative study on the histomorphology and molecular biology of radial artery conduits in patients with diabetes mellitus who underwent coronary bypass surgery.	VWF NOS3	3.47e-05	3	119	2	22972845
Pubmed	Plectin isoform-dependent regulation of keratin-integrin alpha6beta4 anchorage via Ca2+/calmodulin.	ITGB4 PLEC	3.47e-05	3	119	2	19419971
Pubmed	Identification and characterization of a novel tight junction-associated family of proteins that interacts with a WW domain of MAGI-1.	AMOTL1 AMOTL2	3.47e-05	3	119	2	16019084
Pubmed	Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer.	KRT5 KRT6A	3.47e-05	3	119	2	24326984
Pubmed	Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains.	HIF1AN TNKS	3.47e-05	3	119	2	21251231
Pubmed	Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.	KRT5 KRT6A	3.47e-05	3	119	2	17650314
Pubmed	Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes.	ITGB4 PLEC	3.47e-05	3	119	2	19242489
Pubmed	Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms.	KRT6A KRT6C	3.47e-05	3	119	2	7543104
Pubmed	Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains.	AMOTL1 AMOTL2	3.47e-05	3	119	2	12406577
Pubmed	Epidermolysis Bullosa with Pyloric Atresia	ITGB4 PLEC	3.47e-05	3	119	2	20301336
Pubmed	Glucoamylase-like domains in the alpha- and beta-subunits of phosphorylase kinase.	PHKA1 PHKA2	3.47e-05	3	119	2	12876330
Pubmed	Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression.	KRT5 KRT6A	3.47e-05	3	119	2	33086575
Pubmed	Plakophilin 2 affects cell migration by modulating focal adhesion dynamics and integrin protein expression.	ITGB4 PKP2	3.47e-05	3	119	2	23884246
Pubmed	GRAF1 integrates PINK1-Parkin signaling and actin dynamics to mediate cardiac mitochondrial homeostasis.	ARHGAP26 PINK1	3.47e-05	3	119	2	38081847
Pubmed	MuRF1 is a muscle fiber-type II associated factor and together with MuRF2 regulates type-II fiber trophicity and maintenance.	TRIM55 TRIM63	3.47e-05	3	119	2	20149877
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CUL3 CCP110 RANBP10 ARHGAP26 IQSEC2 HIF1AN NEK4 STRN AMOTL1 DCAF11 PLEC SNRPD3 VPS53 TP53BP1 CCDC40	4.67e-05	1321	119	15	27173435
Pubmed	AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis.	KRT5 KRT6A ITGB4	4.97e-05	21	119	3	18824566
Pubmed	The RNF146 and tankyrase pathway maintains the junctional Crumbs complex through regulation of angiomotin.	AMOTL1 TNKS AMOTL2	5.74e-05	22	119	3	27521426
Pubmed	Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP.	AMOTL1 PLEC AMOTL2	6.58e-05	23	119	3	26933062
Pubmed	Angiomotin-like proteins associate with and negatively regulate YAP1.	AMOTL1 AMOTL2	6.93e-05	4	119	2	21187284
Pubmed	Isolation of cDNA clones for the catalytic gamma subunit of mouse muscle phosphorylase kinase: expression of mRNA in normal and mutant Phk mice.	PHKA1 PHKA2	6.93e-05	4	119	2	3472241
Pubmed	Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431.	KRT6A KRT6C	6.93e-05	4	119	2	9054461
Pubmed	Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes.	ITGB4 PLEC	6.93e-05	4	119	2	14668477
Pubmed	Angiomotin'g YAP into the nucleus for cell proliferation and cancer development.	AMOTL1 AMOTL2	6.93e-05	4	119	2	24003252
Pubmed	Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population.	KRT5 KRT6A	6.93e-05	4	119	2	29884220
Pubmed	Phosphorylase Kinase Deficiency	PHKA1 PHKA2	6.93e-05	4	119	2	21634085
Pubmed	Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.	TRIM54 TRIM63	6.93e-05	4	119	2	17786241
Pubmed	The endothelial E3 ligase HECW2 promotes endothelial cell junctions by increasing AMOTL1 protein stability via K63-linked ubiquitination.	AMOTL1 AMOTL2	6.93e-05	4	119	2	27498087
Pubmed	Angiomotin regulates endothelial cell migration during embryonic angiogenesis.	AMOTL1 AMOTL2	6.93e-05	4	119	2	17699752
Pubmed	Perturbation of the titin/MURF1 signaling complex is associated with hypertrophic cardiomyopathy in a fish model and in human patients.	TRIM55 TRIM63	6.93e-05	4	119	2	31628103
Pubmed	Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation.	KRT5 ITGB4	6.93e-05	4	119	2	23571213
Pubmed	Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha.	STRN NOS3	6.93e-05	4	119	2	15569929
Pubmed	Cleavage of phosphorylase kinase and calcium-free calmodulin by HIV-1 protease.	PHKA1 PHKA2	6.93e-05	4	119	2	1872871
Pubmed	A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets.	CEMIP2 CCNG2 TP53BP1	8.50e-05	25	119	3	21536733
Pubmed	Human chromosome 7: DNA sequence and biology.	ZNF212 PCLO IRF5 ATP6V1F ABCB4 TMUB1 FASTK ZNF398 ZNF282	9.90e-05	536	119	9	12690205
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CUL3 KRT5 KRT6A VWF ARHGAP26 PCLO IQSEC2 NCKIPSD KIAA1549 STRN PDE4DIP SSH2 PLEC RASAL1 DNAH11	1.14e-04	1431	119	15	37142655
Pubmed	High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy.	CCDC40 DNAH11	1.15e-04	5	119	2	22499950
Pubmed	Role for keratins 6 and 17 during wound closure in embryonic mouse skin.	KRT5 KRT6A	1.15e-04	5	119	2	12557214
Pubmed	Unaltered striatal dopamine release levels in young Parkin knockout, Pink1 knockout, DJ-1 knockout and LRRK2 R1441G transgenic mice.	KHDRBS2 PINK1	1.15e-04	5	119	2	24733019
Pubmed	The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.	KRT5 KRT6A	1.15e-04	5	119	2	23075894
Pubmed	Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.	AMOTL1 AMOTL2	1.15e-04	5	119	2	21205866
Pubmed	Location of phosphorylase kinase (Phk) in the mouse X chromosome.	PHKA1 PHKA2	1.15e-04	5	119	2	4726088
Pubmed	Airway hillocks are injury-resistant reservoirs of unique plastic stem cells.	KRT5 KRT6A	1.15e-04	5	119	2	38693267
Pubmed	Structural insights into Ca2+-calmodulin regulation of Plectin 1a-integrin β4 interaction in hemidesmosomes.	ITGB4 PLEC	1.15e-04	5	119	2	25703379
Pubmed	Pachyonychia Congenita	KRT6A KRT6C	1.15e-04	5	119	2	20301457
Pubmed	Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12.	KRT5 KRT6A	1.15e-04	5	119	2	1713141
Pubmed	Homologous pairing preceding SPO11-mediated double-strand breaks in mice.	SUN1 PSMC3IP	1.15e-04	5	119	2	23318132
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNA1B NAA15 PCLO IQSEC2 SUN1 STRN ELFN1 PDE4DIP ELAVL4 PLEC PCDH8 RASAL1 TP53BP1	1.47e-04	1139	119	13	36417873
Pubmed	Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators.	KRT5 KRT6A ITGB4	1.64e-04	31	119	3	20930145
Pubmed	ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.	KRT5 ITGB4 PKP2	1.64e-04	31	119	3	22274697
Pubmed	An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption.	VWF MTTP	1.73e-04	6	119	2	20164094
Pubmed	Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse.	KRT5 KRT6A	1.73e-04	6	119	2	16239341
Pubmed	Keratin 6 is not essential for mammary gland development.	KRT5 KRT6A	1.73e-04	6	119	2	16790075
Pubmed	Stem Cell Lineage Infidelity Drives Wound Repair and Cancer.	KRT5 ITGB4	1.73e-04	6	119	2	28434617
Pubmed	Angiomotin functions in HIV-1 assembly and budding.	AMOTL1 AMOTL2	1.73e-04	6	119	2	25633977
Pubmed	Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties.	AMOTL1 AMOTL2	1.73e-04	6	119	2	17397395
Pubmed	Junctional Epidermolysis Bullosa	ITGB4 PLEC	1.73e-04	6	119	2	20301304
Pubmed	p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.	KRT5 KRT6A	1.73e-04	6	119	2	25383540
Pubmed	Characterization of the human COP9 signalosome complex using affinity purification and mass spectrometry.	CUL3 NCKIPSD AMOTL1	1.80e-04	32	119	3	18850735
Pubmed	Primary Ciliary Dyskinesia	DNAAF3 CCDC40 DNAH11	1.80e-04	32	119	3	20301301
Interaction	ZNF767P interactions	ZNF212 ZNF767P ZNF783 ZNF746 TRIM55 TRIM63 ZNF398 ZNF282	1.17e-14	16	116	8	int:ZNF767P
Interaction	ZNF783 interactions	ZNF212 ZNF767P ZNF783 ZNF746 ZNF398	2.60e-09	11	116	5	int:ZNF783
Interaction	ZNF282 interactions	CUL3 ZNF212 ZNF767P ZNF746 ZNF398 ZNF282	2.97e-09	23	116	6	int:ZNF282
Interaction	ZNF398 interactions	CUL3 ZNF212 ZNF767P ZNF783 ZNF746 ZNF398 ZNF282	4.73e-09	43	116	7	int:ZNF398
Interaction	ZNF212 interactions	ZNF212 ZNF767P ZNF783 ZNF746 ZNF398 ZNF282	3.65e-07	49	116	6	int:ZNF212
Interaction	ZNF667-AS1 interactions	TRIM54 TRIM55 TRIM63	1.84e-06	5	116	3	int:ZNF667-AS1
Interaction	KRT6C interactions	KRT5 KRT6A TRIM54 TRIM67 KRT6C PLEC	5.03e-06	76	116	6	int:KRT6C
Interaction	C1orf35 interactions	CUL3 ARHGAP26 TRIM54 CHD9 EVPL ARL4D TRIM67 TRIM55 TRIM63 PINK1	1.05e-05	304	116	10	int:C1orf35
Interaction	KRT31 interactions	CUL3 KRT5 KRT6A VASN INPP5K CCDC187 ITGB4 PRR35 KRT6C PDE4DIP PKP2 AMOTL2	1.20e-05	453	116	12	int:KRT31
Interaction	KRT14 interactions	CUL3 KRT5 KRT6A EVPL ARL4D TRIM67 KRT6C PLEC	1.55e-05	192	116	8	int:KRT14
Interaction	KRT5 interactions	CUL3 KRT5 KRT6A EVPL HIF1AN TRIM67 KRT6C PKP2	1.61e-05	193	116	8	int:KRT5
Interaction	GMDS interactions	CUL3 HIF1AN TRIM67 TNKS TTC38	2.67e-05	61	116	5	int:GMDS
Interaction	ATXN3L interactions	TRIM54 TRIM55 TRIM63	2.96e-05	11	116	3	int:ATXN3L
Interaction	ZNF649 interactions	CUL3 TRIM55 TRIM63	2.96e-05	11	116	3	int:ZNF649
Interaction	EVPL interactions	CUL3 KRT5 EVPL FNDC1 PDE4DIP PINK1	3.41e-05	106	116	6	int:EVPL
Interaction	UBASH3B interactions	CUL3 KRT5 KRT6A PTPN21 PRR35 TRIM67 TNKS	3.49e-05	157	116	7	int:UBASH3B
Interaction	KRT19 interactions	CUL3 KRT5 KRT6A SFI1 TRIM67 KRT6C AMOTL1 PLEC AMOTL2	3.74e-05	282	116	9	int:KRT19
Interaction	C8orf74 interactions	TRIM54 TRIM55 TRIM63	5.10e-05	13	116	3	int:C8orf74
Interaction	KRT38 interactions	CCP110 KRT5 KRT6A KRT6C AMOTL2 VPS53 CCDC40	6.23e-05	172	116	7	int:KRT38
Interaction	MTR interactions	CUL3 ARL4D NEK4 TRIM67 DCAF11 PLEC	6.53e-05	119	116	6	int:MTR
Interaction	ZNF566 interactions	CUL3 TRIM55 TRIM63	8.04e-05	15	116	3	int:ZNF566
Interaction	CLEC12B interactions	PIEZO1 TUSC3 SUN1 GLB1L2 CEMIP2 CSGALNACT2 B4GALNT3	9.52e-05	184	116	7	int:CLEC12B
Interaction	COPS8 interactions	CUL3 NCKIPSD IRF5 TRIM67 DCAF11 PINK1	9.79e-05	128	116	6	int:COPS8
Interaction	LINC00905 interactions	TRIM55 TRIM63	9.82e-05	3	116	2	int:LINC00905
Interaction	UBE2E3 interactions	CUL3 RNF25 TRIM54 ZNF746 TRIM55 TRIM63	1.16e-04	132	116	6	int:UBE2E3
Interaction	ZNF57 interactions	CUL3 TRIM55 TRIM63	1.19e-04	17	116	3	int:ZNF57
Interaction	DCAF11 interactions	CUL3 TRIM67 TRIM55 TRIM63 DCAF11 LRBA	1.37e-04	136	116	6	int:DCAF11
Interaction	KRT16 interactions	CUL3 KRT5 KRT6A TRIM67 KRT6C AMOTL1 PLEC	1.46e-04	197	116	7	int:KRT16
Interaction	KRT18 interactions	CUL3 KNTC1 CCP110 KRT5 KRT6A TRIM67 KRT6C PDE4DIP PKP2 PLEC	1.56e-04	419	116	10	int:KRT18
Interaction	VAC14 interactions	CUL3 PHKA1 TRIM67 PDE4DIP TRIM55 TRIM63 TP53BP1	1.65e-04	201	116	7	int:VAC14
Interaction	KRT84 interactions	CUL3 KRT5 KRT6A KRT6C	1.81e-04	49	116	4	int:KRT84
Interaction	ACTG2 interactions	NEK4 TRIM67 PLEC PINK1	1.81e-04	49	116	4	int:ACTG2
Interaction	LINC00518 interactions	TRIM55 TRIM63	1.96e-04	4	116	2	int:LINC00518
Interaction	LYNX1 interactions	TRIM55 TRIM63	1.96e-04	4	116	2	int:LYNX1
Interaction	APOBEC4 interactions	TRIM55 TRIM63	1.96e-04	4	116	2	int:APOBEC4
Interaction	GOLGA2P5 interactions	TRIM55 TRIM63	1.96e-04	4	116	2	int:GOLGA2P5
Interaction	KYAT1 interactions	TRIM67 TRIM55 TRIM63	1.97e-04	20	116	3	int:KYAT1
Interaction	PHTF1 interactions	KRT5 KRT6A KRT6C	1.97e-04	20	116	3	int:PHTF1
Interaction	IRF3 interactions	IRF5 TRIM67 TRIM55 TRIM63 VPS53 PINK1	2.25e-04	149	116	6	int:IRF3
Cytoband	Ensembl 112 genes in cytogenetic band chr7q36	ZNF212 ZNF767P ZNF783 TMUB1 FASTK ZNF746 ZNF398 ZNF282 NOS3	3.99e-10	159	119	9	chr7q36
Cytoband	7q36.1	ZNF212 ZNF767P ZNF783 TMUB1 ZNF746 ZNF398 ZNF282	1.02e-09	74	119	7	7q36.1
Cytoband	17q25	CEP295NL EVPL ITGB4	1.45e-04	39	119	3	17q25
Cytoband	Ensembl 112 genes in cytogenetic band chr17q25	CEP295NL EVPL ITGB4 NOTUM CCDC40 BAHCC1	1.57e-04	307	119	6	chr17q25
Cytoband	12q13.13	KRT5 KRT6A KRT6C	7.21e-04	67	119	3	12q13.13
GeneFamily	Abhydrolase domain containing	ABHD14A ABHD16B ABHD13	1.08e-04	22	77	3	4
GeneFamily	Keratins, type II	KRT5 KRT6A KRT6C	2.02e-04	27	77	3	609
GeneFamily	EF-hand domain containing\|Plakins	EVPL PLEC	4.93e-04	8	77	2	939
GeneFamily	Fibronectin type III domain containing	INSRR ITGB4 FNDC1 TRIM67 ELFN1	6.03e-04	160	77	5	555
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM54 TRIM67 TRIM55 TRIM63	7.22e-04	95	77	4	59
GeneFamily	Beta 4-glycosyltransferases	CSGALNACT2 B4GALNT3	2.34e-03	17	77	2	425
ToppCell	IPF-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	ABCC3 KRT5 KRT6A KHDRBS2 ITGB4 ARL4D AMOTL1	7.61e-07	190	118	7	4f15842b424eefadbfe451875e517cf70e29607f
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL1 AMOTL2 NOS3	8.17e-07	192	118	7	1990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL1 AMOTL2 NOS3	8.17e-07	192	118	7	845cc9c18b4436b07dd3ce7980052683937546d2
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL1 AMOTL2 NOS3	8.17e-07	192	118	7	c72a082c93a8825adbfef37f889ba3a7052f201b
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KRT5 PCLO TUSC3 SUN1 EVPL ITGB4 DUOX1	1.07e-06	200	118	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KRT5 PCLO TUSC3 SUN1 EVPL ITGB4 DUOX1	1.07e-06	200	118	7	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	droplet-Marrow-BM-1m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT6A IQSEC2 IRF5 PHKA2 BAHCC1 DNAH11	5.78e-06	168	118	6	2e88d9cb7c80a4656fab290db8b45a5a0599d769
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	GPLD1 RANBP10 VWF ABCB4 ELFN1 PINK1	6.40e-06	171	118	6	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 PKP2 AMOTL2 NOS3	6.61e-06	172	118	6	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 PKP2 AMOTL2 NOS3	6.61e-06	172	118	6	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF IP6K3 MDGA2 ITGB4 CEMIP2 NOS3	7.30e-06	175	118	6	2e54961846c65b185d9bd6e305dd81205579d890
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF IP6K3 MDGA2 ITGB4 CEMIP2 NOS3	7.30e-06	175	118	6	efa6a05f7417d46141b6e635f258c126b7a03aa1
ToppCell	Caecum-Dendritic_cell-cDC1\|Dendritic_cell / Region, Cell class and subclass	CC2D1A SFI1 CCNG2 DCAF11 VPS53 SNX22	7.54e-06	176	118	6	07cde50e1c18fcc2c5028efe1a087db4ef4d4783
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF CCNG2 FNDC1 ELFN1 PKP2 PCDH8	8.05e-06	178	118	6	2a36475c260088f69f3b8c282d910e5eaa5c5c2d
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF EVPL MDGA2 ITGB4 CEMIP2 NOS3	8.31e-06	179	118	6	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCP110 GLB1L2 SLC44A4 DNAAF3 CCDC40 DNAH11	8.58e-06	180	118	6	92fb01b91261b3103454924cde56add337b41844
ToppCell	AT1-AT2_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM5 KHDRBS2 EVPL PTPN21 AMOTL2 SNX22	8.85e-06	181	118	6	ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	PCLO KHDRBS2 PTPN21 FNDC1 AMOTL2 SNX22	9.42e-06	183	118	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF CCNG2 FNDC1 ELFN1 PKP2 PCDH8	1.00e-05	185	118	6	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF CCNG2 ELFN1 PKP2 ARHGAP28 PCDH8	1.10e-05	188	118	6	6ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPLD1 KIAA1549 ABCB4 ELFN1 ELAVL4 SNX22	1.10e-05	188	118	6	7471c194276161422326647f09022e94f3d1640c
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KHDRBS2 KIAA1549 TRIM67 ELFN1 ELAVL4 SNX22	1.10e-05	188	118	6	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPLD1 KIAA1549 ABCB4 ELFN1 ELAVL4 SNX22	1.10e-05	188	118	6	053c251d3ddbeb866f34565aefca4535517b4387
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KHDRBS2 KIAA1549 TRIM67 ELFN1 ELAVL4 SNX22	1.10e-05	188	118	6	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KHDRBS2 KIAA1549 ABCB4 TRIM67 ELFN1 SNX22	1.17e-05	190	118	6	9b825b2586c7b173ff27fcf2abc5860faf50984a
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KHDRBS2 KIAA1549 ABCB4 TRIM67 ELFN1 SNX22	1.17e-05	190	118	6	d146af1926474328a7c822bc140c4dda66e1bbfb
ToppCell	droplet-Lung-nan-21m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 ARL4D AMOTL2 NOS3	1.20e-05	191	118	6	92b2faa72c184b6ae49530fd3b50848510904997
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	KNTC1 MMS22L SUN1 SFI1 CEMIP2 LRBA	1.20e-05	191	118	6	9454f642c3621370fa23640b631301346b300950
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 ARL4D AMOTL1 NOS3	1.20e-05	191	118	6	9fc674a58f20b47255e4457d5195c8cff17b0414
ToppCell	droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 ARL4D AMOTL1 NOS3	1.20e-05	191	118	6	c379a499dabf3c9ed80f47adbb2d949821c5b053
ToppCell	droplet-Lung-nan-21m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 ARL4D AMOTL2 NOS3	1.20e-05	191	118	6	d0bbbf42d00165a53253c833adef65da6ec36bba
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	KRT5 PTPN21 SLC44A4 PHKA1 B4GALNT3 AMOTL2	1.24e-05	192	118	6	8899d81306770adda893b5e146df1253971754c5
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	KRT5 PTPN21 SLC44A4 PHKA1 B4GALNT3 AMOTL2	1.24e-05	192	118	6	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	droplet-Lung-21m-Endothelial-venous_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL2 NOS3	1.31e-05	194	118	6	db7b0c77ad88f7b74d85679f1fb8ee7140ac3f62
ToppCell	droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL2 NOS3	1.31e-05	194	118	6	17d530982789acc5e6889b215f3d433d138a41c4
ToppCell	droplet-Lung-21m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL2 NOS3	1.31e-05	194	118	6	5992b9409d5855eff2afc3acd201ccd25420d2e0
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL1 NOS3	1.35e-05	195	118	6	0c15be3e7c238e329505dcbbe197a977d1019d45
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL1 NOS3	1.35e-05	195	118	6	45ac0fdbeb0982d798c613a6d15715d725608aa9
ToppCell	droplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D AMOTL1 NOS3	1.35e-05	195	118	6	5b1f04a745467876b09113ee17ababd3fcf9fb01
ToppCell	NS-control-d_0-4-Epithelial-Squamous\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KRT6A CEACAM5 VWF VASN CCNG2 RASAL1	1.43e-05	197	118	6	ab965a0ba87efd3329d24a1ec123985f46fc17c0
ToppCell	control-Epithelial-Squamous\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KRT6A CEACAM5 VWF VASN CCNG2 RASAL1	1.47e-05	198	118	6	6ba669ac1ed275ae309054941b1457e315766faa
ToppCell	5'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC3 CEACAM5 VASN SLC44A4 PKP2 B4GALNT3	1.47e-05	198	118	6	db26c20321f9ab102d6484f22ddb2bde684067b1
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCC3 KRT5 KRT6A KHDRBS2 ITGB4 DUOX1	1.52e-05	199	118	6	94a7867e800df352731796de8c24cba133c29622
ToppCell	(02)_MMP9/10+-(1)_GFP\|(02)_MMP9/10+ / shred by cell type by condition	KRT5 KRT6A PIEZO1 ITGB4 CEMIP2 PLEC	1.52e-05	199	118	6	448ba982be804007f991d469eca9d885b21ae499
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	CACNA1B PCLO ARL4D PDE4DIP ELAVL4 PCDH8	1.52e-05	199	118	6	77b4aa00f14b86ef5db0490be98787e063979541
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 KRT6A ITPRID1 ITGB4 PKP2 RASAL1	1.56e-05	200	118	6	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	VWF ITGB4 ARL4D ELFN1 PLEC NOS3	1.56e-05	200	118	6	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	VGF CCNG2 ELFN1 PKP2 ARHGAP28 PCDH8	1.56e-05	200	118	6	75649534a98bc738fca62d071de0978dc61eb24f
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Thalamus / BrainAtlas - Mouse McCarroll V32	KRT5 VWF IP6K3 PIEZO1 NOS3	2.80e-05	133	118	5	29b0c2c682c6b97823e7d8d8ba1f5114044b30ba
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CCDC187 ITGB4 FNDC1 ARHGAP28 CCDC40	3.23e-05	137	118	5	5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3
ToppCell	AT1-AT2_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM5 KHDRBS2 PTPN21 AMOTL2 SNX22	3.58e-05	140	118	5	45d52a086ced8d58e01ac51ac4a90338e8649b16
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IP6K3 TRIM54 PHKA1 ASB8 TRIM63	4.10e-05	144	118	5	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IP6K3 GLB1L2 ABCB4 ELFN1 PCDH8	4.24e-05	145	118	5	590ba937c741ae67460f303eca88b1cd3ac87f64
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	KRT5 GLB1L2 ELFN1 PKP2 PCDH8	4.82e-05	149	118	5	98ae408d2d0347865875ff8bbd89d359decea526
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	ABCC3 SNX24 IRF5 NCF2 PKP2	6.00e-05	156	118	5	1a0e081284a99c1b345990775015b8a2fa469496
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	PCLO CCDC187 ARHGEF25 LRBA DNAH11	6.00e-05	156	118	5	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT6A KHDRBS2 GLB1L2 ARL4D	6.76e-05	160	118	5	8590281165eab6514a9f6a022b900d4c222c1044
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPLD1 ARL4D ABCB4 NOTUM MTTP	6.76e-05	160	118	5	c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCell	facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD14A KRT5 NCKIPSD PTPN21 SNX22	7.17e-05	162	118	5	497ae9f86a5e7946d0fde932b35719a382a6b691
ToppCell	facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD14A KRT5 NCKIPSD PTPN21 SNX22	7.17e-05	162	118	5	7b2949eba2b4aea239d96ed82aafab13b07624eb
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	GPLD1 ABCC3 SNX24 CCNG2 MTTP	7.17e-05	162	118	5	7d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCell	droplet-Lung-nan-18m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP26 IRF5 NCF2 CSGALNACT2 SSH2	7.82e-05	165	118	5	e32697321cef424c2ad4e11ee9da3e510d5ce505
ToppCell	droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP26 IRF5 NCF2 CSGALNACT2 SSH2	7.82e-05	165	118	5	0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09
ToppCell	facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF IP6K3 SNX24 CEMIP2 NOS3	8.28e-05	167	118	5	a4a795751644b22af616335379e64ae95175180c
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF EVPL CEMIP2 PLEC NOS3	8.51e-05	168	118	5	32e4d82efaccf336d347e4063253c3635a3ec672
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 ARL4D NOS3	8.75e-05	169	118	5	8dba7546adc6b1345933eec81fc77fc9611fae60
ToppCell	facs-Lung-Endomucin-24m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF ITGB4 CEMIP2 ARL4D NOS3	8.75e-05	169	118	5	d2862a7ddee6d7a65d84ef9d0800ba6f4690973f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PARD3B ABCB4 FNDC1 ELFN1 ARHGAP28	9.00e-05	170	118	5	31e3f57673c99f4d8ef30faa9c40e5f7f5bf6460
ToppCell	facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 TRIM54 EVPL CCDC40 BAHCC1	9.00e-05	170	118	5	d70aaa0f4e5034bb9f61b832b5f9123870936d3c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IP6K3 ELFN1 AMOTL1 PKP2 PCDH8	9.00e-05	170	118	5	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KRT5 KRT6A EVPL ITGB4 DUOX1	9.77e-05	173	118	5	1b2508cc890430bd4b2cf232c633928edb86c57e
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IP6K3 PTPN21 DNAAF3 PDE4DIP BAHCC1	1.00e-04	174	118	5	7be0c6248e77f2d0260b852b01e17892f7828f1b
ToppCell	PCW_10-12-Epithelial-Epithelial_ciliated\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CCDC187 GLB1L2 SLC44A4 DNAAF3 CFAP99	1.00e-04	174	118	5	b8d1c556290d188f56aeefc17f03119686945fe7
ToppCell	CV-Healthy-4\|Healthy / Virus stimulation, Condition and Cluster	INSRR NCKIPSD CCNG2 AMOTL1 ZNF282	1.00e-04	174	118	5	26544cc5f51cb4dc1251e62d9f80b6c956194d38
ToppCell	PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CCDC187 GLB1L2 SLC44A4 DNAAF3 CFAP99	1.00e-04	174	118	5	00cf27bc23af1472a507be31fba6245a8fdd901b
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPN21 DNAAF3 PDE4DIP ARHGAP28 BAHCC1	1.03e-04	175	118	5	1b910c08d2bfbcc77431ee66103e63a11a9d39fe
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CC2D1A MDGA2 PHKA1 DUOX1 BAHCC1	1.03e-04	175	118	5	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF CCNG2 FNDC1 PKP2 PCDH8	1.03e-04	175	118	5	9d09636a103daa8f622c3dbfd1f1536aaec3b6bb
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 VWF INSRR SLC44A4 ELFN1	1.03e-04	175	118	5	0992de1c7bffcb6890584357a7a0a8955927da6c
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMS22L EVPL CC2D1A ITGB4 DNAH11	1.06e-04	176	118	5	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GLB1L2 ELFN1 AMOTL1 PKP2 PCDH8	1.06e-04	176	118	5	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MMS22L EVPL CC2D1A ITGB4 DNAH11	1.06e-04	176	118	5	aa1bada2175d8370fc71939a607407155259d195
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FNDC1 ELFN1 PKP2 ARHGAP28 PCDH8	1.09e-04	177	118	5	84116796ca4c7007508c0f1a68a1135c7b922278
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5\|TCGA-Lung / Sample_Type by Project: Shred V9	KRT5 KRT6A FRMD8 ARL4D KRT6C	1.09e-04	177	118	5	a0c7d08469c513cecf87777c19876884f1511570
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	MMS22L SUN1 SFI1 CEMIP2 TNKS	1.09e-04	177	118	5	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF CCNG2 ELFN1 PKP2 PCDH8	1.09e-04	177	118	5	d7976eac7e27044f6a859cc0c3398d08576e8c01
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TNFSF13 INSRR SPTBN5 TRIM63	1.10e-04	93	118	4	af489f0dd76c3c1a84d164283149f550a7ece91c
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TNFSF13 INSRR SPTBN5 TRIM63	1.10e-04	93	118	4	c1d0afcfa37c2dcbb12189b4ce56ae7c4bb7ba30
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TNFSF13 INSRR SPTBN5 TRIM63	1.10e-04	93	118	4	0ea74c2820372d60d3804bf2c8bb0d03733dff98
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT6A KHDRBS2 GLB1L2 AMOTL1	1.12e-04	178	118	5	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT6A KHDRBS2 GLB1L2 AMOTL1	1.12e-04	178	118	5	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 B4GALNT3 NOS3	1.12e-04	178	118	5	ebfae386a518ea33911ba3ff40464c94d18ef695
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FNDC1 ELFN1 PKP2 ARHGAP28 PCDH8	1.12e-04	178	118	5	3c973aac16988e88f5677d3d695dd772ccfd6570
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 B4GALNT3 NOS3	1.12e-04	178	118	5	ccd37575b60102f5e647c01546e8ff8fec638bd7
ToppCell	facs-Lung-18m-Endothelial-venous_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 B4GALNT3 NOS3	1.12e-04	178	118	5	87b04753650e45f12299c8456fb980d6c0d5961c
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	GPLD1 CACNA1B PCLO INSRR ELAVL4	1.15e-04	179	118	5	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D NOS3	1.18e-04	180	118	5	178648429686e6d4e6f3aafc350130e819788ecf
ToppCell	facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D NOS3	1.18e-04	180	118	5	fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2
ToppCell	facs-Lung-24m-Endothelial-venous_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D NOS3	1.18e-04	180	118	5	c2a8f61c806f6f6f47743e9f7c9700705db43386
ToppCell	facs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF ITGB4 CEMIP2 ARL4D NOS3	1.21e-04	181	118	5	72c28baf4fd417ff4a7068603830d55074960144
Drug	Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; PC3; HT_HG-U133A	VGF CEACAM5 ARHGAP26 IRF5 PTPN21 ITGB4 ZNF783 CCNG2 BAHCC1	8.25e-07	195	118	9	4581_DN
Drug	plakin	KRT6A EVPL ITGB4 SPTBN5 KRT6C PLEC	4.33e-06	82	118	6	CID000018752
Drug	mant-GTP	KRT6A SUN1 ITGB4 KRT6C PLEC	6.04e-06	50	118	5	CID000128647
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A	GLB1L2 STRN FASTK PLEC ZNF282 VPS53 TTC38 BAHCC1	7.90e-06	194	118	8	3509_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	ABCC3 INPP5K PIEZO1 ITGB4 ZNF783 PDE4DIP DCAF11 TTC38	7.90e-06	194	118	8	4284_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A_EA	INPP5K ZNF212 TUSC3 IRF5 CEMIP2 PLEC ZNF282 PINK1	8.52e-06	196	118	8	1002_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ABCC3 TUSC3 CC2D1A IRF5 GLB1L2 HIF1AN PHKA2 PDE4DIP	8.84e-06	197	118	8	6773_DN
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	VGF RANBP10 CC2D1A IRF5 PHKA2 FASTK DCAF11 PINK1	9.18e-06	198	118	8	5475_DN
Drug	alpha-estradiol; Down 200; 0.01uM; ssMCF7; HG-U133A	RANBP10 SNX24 CCNG2 FASTK PDE4DIP PSMC3IP JRKL TP53BP1	9.52e-06	199	118	8	403_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	INPP5K SUN1 IRF5 PTPN21 CCNG2 TTC38 RASAL1	4.33e-05	180	118	7	7420_UP
Drug	CaLam	ABCC3 KRT6A ABCB4 KRT6C	4.90e-05	39	118	4	CID004126474
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	ABCC3 INPP5K SFI1 ITGB4 CCNG2 PDE4DIP PINK1	5.51e-05	187	118	7	5224_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	ERCC2 INPP5K IQSEC2 KHDRBS2 CC2D1A CCNG2 DCAF11	6.30e-05	191	118	7	6959_UP
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A	ARHGAP26 IQSEC2 IRF5 SFI1 PTPN21 PDE4DIP PLEC	6.30e-05	191	118	7	3890_DN
Drug	phorbol 12-myristate	GPLD1 KRT5 KRT6A NAA15 NCF2 KRT6C LRBA PCDH8	6.61e-05	261	118	8	CID000107854
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	SFI1 PTPN21 ITGB4 CCNG2 PDE4DIP ARHGAP28 AMOTL2	6.73e-05	193	118	7	4466_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	INPP5K IQSEC2 SUN1 ARL4D PLEC TTC38 BAHCC1	6.95e-05	194	118	7	3859_DN
Drug	Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A	SNX24 ARHGAP26 CHD9 PTPN21 STRN AMOTL2 TTC38	7.18e-05	195	118	7	1831_UP
Drug	AC1L9LMC	KNTC1 KRT6A ITGB4 KRT6C PLEC	7.22e-05	83	118	5	CID000448113
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	RNF25 ITGB4 DCAF11 PLEC VPS53 TTC38 BAHCC1	7.41e-05	196	118	7	7356_DN
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; HL60; HT_HG-U133A	SFI1 ITGB4 HIF1AN ZNF783 ARL4D FASTK PDE4DIP	7.41e-05	196	118	7	2207_DN
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A	VGF INPP5K IQSEC2 SUN1 PHKA2 PINK1 BAHCC1	7.41e-05	196	118	7	3217_DN
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	RANBP10 SUN1 IRF5 PTPN21 CCNG2 PDE4DIP RASAL1	7.41e-05	196	118	7	7432_UP
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A	ARHGAP26 EVPL IRF5 SFI1 GLB1L2 PDE4DIP VPS53	7.41e-05	196	118	7	4508_UP
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	ABCC3 INPP5K TUSC3 EVPL FASTK PLEC TTC38	7.65e-05	197	118	7	7347_DN
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; MCF7; HT_HG-U133A	INPP5K IRF5 ZNF783 CCNG2 STRN PDE4DIP VPS53	7.65e-05	197	118	7	4714_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA	VGF RANBP10 SUN1 NCKIPSD PDE4DIP VPS53 PINK1	7.65e-05	197	118	7	1013_UP
Drug	Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	VGF ERCC2 ARL4D PHKA2 STRN PDE4DIP PINK1	7.65e-05	197	118	7	3447_UP
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	ABCC3 EVPL FASTK PDE4DIP PLEC ZNF282 TTC38	7.65e-05	197	118	7	4354_DN
Drug	Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A	VGF CC2D1A IRF5 PTPN21 PHKA2 PLEC TP53BP1	7.65e-05	197	118	7	7201_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	ABCC3 IQSEC2 SFI1 ITGB4 DUOX1 PDE4DIP VPS53	7.65e-05	197	118	7	2654_UP
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	VGF KNTC1 INPP5K ITGB4 CCNG2 PLEC TTC38	7.65e-05	197	118	7	4829_DN
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	VGF INPP5K PCLO NCKIPSD SFI1 JRKL RASAL1	7.65e-05	197	118	7	5453_DN
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A	ERCC2 ZNF212 SUN1 EVPL ITGB4 ZNF783 PHKA2	7.65e-05	197	118	7	4363_DN
Drug	Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ABHD14A INPP5K ZNF212 NCKIPSD PTPN21 STRN DCAF11	7.65e-05	197	118	7	5468_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	INPP5K RNF25 EVPL CC2D1A PTPN21 PHKA2 PLEC	7.90e-05	198	118	7	7180_DN
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	ABCC3 INPP5K ZNF783 SPTBN5 PDE4DIP PLEC TTC38	7.90e-05	198	118	7	5393_DN
Drug	Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A	GPLD1 INPP5K KHDRBS2 SFI1 PTPN21 CCNG2 PDE4DIP	7.90e-05	198	118	7	6524_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A	ARHGAP26 IQSEC2 SUN1 CC2D1A PDE4DIP VPS53 TTC38	7.90e-05	198	118	7	4669_DN
Drug	Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; PC3; HT_HG-U133A	ABCC3 SFI1 ITGB4 ZNF783 CCNG2 PDE4DIP RASAL1	7.90e-05	198	118	7	3725_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; PC3; HT_HG-U133A	EVPL HIF1AN CEMIP2 ASB8 PDE4DIP DCAF11 TTC38	7.90e-05	198	118	7	2120_DN
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	ABCC3 PTPN21 ZNF783 CCNG2 STRN PDE4DIP TTC38	7.90e-05	198	118	7	6965_UP
Drug	Practolol [6673-35-4]; Down 200; 15uM; PC3; HT_HG-U133A	TUSC3 RNF25 PTPN21 ITGB4 HIF1AN CCNG2 PLEC	8.15e-05	199	118	7	4603_DN
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; HL60; HT_HG-U133A	SUN1 SFI1 ITGB4 STRN PDE4DIP VPS53 BAHCC1	8.15e-05	199	118	7	2713_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	PCLO IQSEC2 SUN1 CC2D1A ITGB4 HIF1AN SPTBN5	8.15e-05	199	118	7	6256_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	VGF IQSEC2 IRF5 PTPN21 PDE4DIP RASAL1 BAHCC1	8.15e-05	199	118	7	3203_DN
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; MCF7; HT_HG-U133A	ERCC2 ARHGAP26 IQSEC2 SFI1 ABCB4 PKP2 TTC38	8.41e-05	200	118	7	5454_UP
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A	VGF CC2D1A NCF2 HIF1AN ZNF783 FASTK RASAL1	8.41e-05	200	118	7	1368_UP
Drug	AC1L1R04	KNTC1 EVPL ELAVL4 PLEC	1.03e-04	47	118	4	CID000008439
Drug	NSC648766	ABCC3 ERCC2 ABCB4 CCNG2 PLEC	1.24e-04	93	118	5	CID000003199
Drug	D-alanyl-D-lactate	TRIM55 TRIM63	1.59e-04	4	118	2	CID005487001
Drug	MMTP	INSRR MTTP	1.59e-04	4	118	2	CID000018391
Disease	visceral heterotaxy (implicated_via_orthology)	CC2D1A PHKA2 DNAAF3 DNAH11	1.40e-05	37	117	4	DOID:0050545 (implicated_via_orthology)
Disease	Junctional epidermolysis bullosa with pyloric atresia	ITGB4 PLEC	1.56e-05	2	117	2	cv:C5676875
Disease	Epidermolysis Bullosa Simplex With Pyloric Atresia	ITGB4 PLEC	1.56e-05	2	117	2	C2677349
Disease	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA	ITGB4 PLEC	1.56e-05	2	117	2	226730
Disease	Epidermolysis bullosa with pyloric atresia	ITGB4 PLEC	4.66e-05	3	117	2	C1856934
Disease	Epidermolysis Bullosa Herpetiformis Dowling-Meara	KRT5 ITGB4	4.66e-05	3	117	2	C0079295
Disease	Epidermolysis Bullosa Simplex Kobner	KRT5 ITGB4	4.66e-05	3	117	2	C0079299
Disease	Weber-Cockayne Syndrome	KRT5 ITGB4	4.66e-05	3	117	2	C0080333
Disease	Epidermolysis Bullosa	KRT5 ITGB4	9.30e-05	4	117	2	C0014527
Disease	Glycogen phosphorylase kinase deficiency	PHKA1 PHKA2	9.30e-05	4	117	2	cv:C0268147
Disease	Epidermolysis Bullosa Simplex	KRT5 ITGB4	1.55e-04	5	117	2	C0079298
Disease	Aplasia Cutis Congenita	ITGB4 PLEC	2.31e-04	6	117	2	C0282160
Disease	septic shock	MMS22L ARHGAP26	3.23e-04	7	117	2	EFO_0006834
Disease	epidermolysis bullosa simplex (is_implicated_in)	KRT5 PLEC	3.23e-04	7	117	2	DOID:4644 (is_implicated_in)
Disease	diverticular disease	MMS22L SNX24 PIEZO1 NOTUM ELFN1 PKP2	3.67e-04	236	117	6	EFO_0009959
Disease	Primary ciliary dyskinesia	DNAAF3 CCDC40 DNAH11	3.94e-04	36	117	3	cv:C0008780
Disease	glycogen storage disease (is_implicated_in)	PHKA1 PHKA2	5.51e-04	9	117	2	DOID:2747 (is_implicated_in)
Disease	Primary Ciliary Dyskinesia	DNAAF3 CCDC40 DNAH11	8.68e-04	47	117	3	C4551720
Disease	Primary biliary cirrhosis	IRF5 ABCB4 NOS3	8.68e-04	47	117	3	C0008312
Disease	cholestasis (biomarker_via_orthology)	ABCC3 ABCB4 NOS3	9.80e-04	49	117	3	DOID:13580 (biomarker_via_orthology)
Disease	disease recurrence, colon carcinoma	ZNF767P ZNF746 AMOTL1	1.10e-03	51	117	3	EFO_0004952, EFO_1001950
Disease	hypothyroidism (implicated_via_orthology)	PHKA1 DUOX1	1.18e-03	13	117	2	DOID:1459 (implicated_via_orthology)
Disease	hippocampal volume	PARD3B ITPRID1 STRN ZNF398 PLEC DNAH11	1.22e-03	297	117	6	EFO_0005035
Disease	Kartagener syndrome (implicated_via_orthology)	DNAAF3 DNAH11	1.38e-03	14	117	2	DOID:0050144 (implicated_via_orthology)
Disease	brain measurement, neuroimaging measurement	SNX24 HIF1AN DNAAF3 STRN SSH2 PLEC BAHCC1 DNAH11	1.60e-03	550	117	8	EFO_0004346, EFO_0004464
Disease	Pontoneocerebellar hypoplasia	PCLO VPS53	1.80e-03	16	117	2	cv:C1261175
Disease	Glycogen storage disease	PHKA1 PHKA2	2.04e-03	17	117	2	cv:C0017919
Disease	Gastric ulcer	VGF NOS3	2.29e-03	18	117	2	C0038358
Disease	familial hyperlipidemia (biomarker_via_orthology)	MTTP NOS3	2.55e-03	19	117	2	DOID:1168 (biomarker_via_orthology)
Disease	Cholecystitis	ABCB4 LRBA	2.55e-03	19	117	2	HP_0001082
Disease	autism spectrum disorder (implicated_via_orthology)	NAA15 CHD9 PKP2 LRBA	3.20e-03	152	117	4	DOID:0060041 (implicated_via_orthology)
Disease	platelet-to-lymphocyte ratio	KNTC1 RANBP10 VWF IP6K3 STRN PLEC	3.31e-03	363	117	6	EFO_0008446
Disease	Bronchiectasis	CCDC40 DNAH11	3.42e-03	22	117	2	C0006267
Disease	Paroxysmal atrial fibrillation	VWF SUN1 PKP2 NOS3	3.51e-03	156	117	4	C0235480
Disease	familial atrial fibrillation	VWF SUN1 PKP2 NOS3	3.51e-03	156	117	4	C3468561
Disease	Persistent atrial fibrillation	VWF SUN1 PKP2 NOS3	3.51e-03	156	117	4	C2585653
Disease	asparaginase hypersensitivity	CACNA1B IP6K3 ARHGAP28	3.59e-03	77	117	3	EFO_0004881
Disease	sphingomyelin 24:1 measurement	MMS22L TUSC3	3.73e-03	23	117	2	EFO_0010398
Disease	Atrial Fibrillation	VWF SUN1 PKP2 NOS3	3.84e-03	160	117	4	C0004238

Protein segments in the cluster

Peptide	Gene	Start	Entry
LNRDDIGIILINQYI	ATP6V1F	56	Q16864
GIRLNLILIRYTGDN	ABHD13	96	Q7L211
QLQRLAEELRRGYQE	CEP295NL	106	Q96MC4
VLHRLIQEQLRYGNL	AMOTL2	11	Q9Y2J4
IVIEGERGNRQRIYS	BAHCC1	1941	Q9P281
QVLQLGYNRLRNLTE	ELFN1	111	P0C7U0
RLQEVYRQQREAVLG	CCDC187	671	A0A096LP49
GRDRIVFGNIQQIYE	ARHGEF25	201	Q86VW2
VDGLGLQQGLERLYE	ARL4D	171	P49703
QDQLRGGRYLLELEL	B4GALNT3	701	Q6L9W6
GGRYLLELELLEQGQ	B4GALNT3	706	Q6L9W6
ERVDGNRQIIGYVIG	CEACAM5	71	P06731
EGEGYINLNQVRRRD	C4orf47	71	A7E2U8
QLLGLLNVYLEQEER	CCNG2	16	Q16589
GIQELRVDLANLYIR	DNAH11	2886	Q96DT5
GTVLQRLIQEQLRYG	AMOTL1	96	Q8IY63
ASLNGYRLGDRVLQV	ELAVL4	361	P26378
RRQQQIERELNGYLE	CACNA1B	376	Q00975
LLQQGQERLVERYHG	ABHD16B	126	Q9H3Z7
AQTVYRQLLLGRDQL	RASAL1	726	O95294
RELQALSEQLGREYG	RANBP10	516	Q6VN20
LNRLVTGIDNYGQGR	INTS6	101	Q9UL03
GIRQGELQLLRTAAY	ABCC3	516	O15438
QRAAIILGYRIQGVI	KIAA1549	1266	Q9HCM3
EQLGTLQLLSQRGYR	ABHD14A	111	Q9BUJ0
LDYGAEVRVINLIGQ	ASB8	171	Q9H765
AILREGALYQRQVEQ	CFAP99	301	D6REC4
GALYQRQVEQELQRV	CFAP99	306	D6REC4
VYLQPGQIRVVDGRL	DUOX1	661	Q9NRD9
AEGLRQLLGEEKYRQ	FASTK	406	Q14296
LRVGELTQQALQRYL	PARD3B	21	Q8TEW8
QYINNLRRQLDSIVG	KRT6C	216	P48668
GAAGILLRYLQEQNR	PSMC3IP	11	Q9P2W1
LRGNQLIDYKILGLQ	NCF2	101	P19878
FQLGDRAQQIREGIL	ITPRID1	926	Q6ZRS4
QQRGGEERLYLQQTL	HIF1AN	136	Q9NWT6
QYINNLRRQLDSIVG	KRT6A	216	P02538
QLLGNVIEQYIGRFL	MMS22L	1021	Q6ZRQ5
GEQGLLNAYRQVQEV	FRMD8	226	Q9BZ67
NSGVRLDGYARLVQQ	PHKA1	6	P46020
RDLLVGIYQRIQGRE	IQSEC2	926	Q5JU85
GIYQRIQGRELRTND	IQSEC2	931	Q5JU85
QYINNLRRQLDSIVG	KRT5	221	P13647
GEIQLQINYDLGNLI	PCLO	4696	Q9Y6V0
RRLQGFRLEEYLIGQ	PINK1	146	Q9BXM7
GILRRSNLNIFQYIG	MTTP	641	P55157
LGRNGQVTYRLLEAE	PCDH8	526	O95206
VIRGLGVQLLEQVYD	NEK4	786	P51957
GIIDRGQYLQLQELE	EVPL	1706	Q92817
DLAQVLAYLLRRGQV	DCAF11	41	Q8TEB1
LAYLLRRGQVRLVQG	DCAF11	46	Q8TEB1
ALQRAYALLQEQVGG	JAKMIP3	511	Q5VZ66
NIRAIQLSRDGQYLL	LRBA	2781	P50851
REDIAVIRNYGNLLL	ERCC2	511	P18074
LRGYGIREVNLLNKE	KNTC1	846	P50748
RNYRAGLLQNNLEEG	JRKL	336	Q9Y4A0
LDRGLILQLQGQDLY	IRF5	321	Q13568
GNIGLVALIYIEQRL	OR5K3	41	A6NET4
RRGEVGIYQVQLRAL	ITGB4	401	P16144
GYIFGLENLIRILQD	IP6K3	391	Q96PC2
ELLLYQNQVLREAGL	NAA15	191	Q9BXJ9
QNQVLREAGLYREAL	NAA15	196	Q9BXJ9
DRIVAYRLGIRQAGQ	MDGA2	666	Q7Z553
GRYQIINGLRRFEIE	SMPD4	711	Q9NXE4
RNFNVNYLREIIGVV	ABCB4	461	P21439
EAGDVIGVLRDQQRY	NOS3	1141	P29474
AQIDLNGRIRNGSVY	PTPN21	381	Q16825
ALGDYARVEQRLGQL	PRR35	411	P0CG20
VQEGLRLYIQNLGRE	NOTUM	356	Q6P988
LQERRNVGANGIGYQ	CSGALNACT2	96	Q8N6G5
ALGQQQYLTRLRELQ	CHD9	2376	Q3L8U1
LARYLVDVRQEQLQG	DNAAF3	411	Q8N9W5
DRGLVLNAEGRYLQD	FNDC1	1361	Q4ZHG4
NLGLIIFRDQVVRYG	CUL3	141	Q13618
RNLNLDIYVIGLQEL	INPP5K	41	Q9BT40
RAQRQELGVNLYEVQ	CCDC40	321	Q4G0X9
RAQLEQGGVGIRREY	CC2D1A	891	Q6P1N0
QERLGSELIQGLGYR	CEMIP2	331	Q9UHN6
QERVLAQLRAALYGI	CCP110	856	O43303
EGSLILNLRQGYNLE	INSRR	351	P14616
EIRQEQLRELSYLNG	KHDRBS2	166	Q5VWX1
QRSVFNLQIYGVLGL	SLC44A4	436	Q53GD3
LHRIYLRGRNEEQGI	DCK	186	P27707
QGYTVLRILVENRGR	GLB1L2	476	Q8IW92
LRILVENRGRVNYGE	GLB1L2	481	Q8IW92
NSGVRLDGYARLVQQ	PHKA2	6	P46019
YQGQLLQEGATRLLR	SFI1	881	A8K8P3
KQGRQLLRQYLQEVG	STRN	156	O43815
LLLQYLLQGGARQRG	VGF	331	O15240
ETRGINEQGLYRIVG	ARHGAP26	401	Q9UNA1
NEQGLYRIVGVNSRV	ARHGAP26	406	Q9UNA1
AYLRRLQGLEQDVLQ	NCKIPSD	51	Q9NZQ3
GNLLRYQQQLEGALE	SPTBN5	2351	Q9NRC6
GLQRNLLVENIIDIY	TRIM63	91	Q969Q1
VLGTLLQEYGLLQRR	ZNF767P	66	Q75MW2
LQEYGLLQRRLENVE	ZNF767P	71	Q75MW2
GVYGLQRNLLVENII	TRIM54	91	Q9BYV2
LLEAIVQRYQQGRGA	TRIM67	181	Q6ZTA4
VGGLLYLRRNNLEFI	TUSC3	211	Q13454
ALQQALNERDGLYGR	TEX13D	131	A0A0J9YY54
LNERDGLYGRLLQIE	TEX13D	136	A0A0J9YY54
GVYGLQRNLLVENII	TRIM55	91	Q9BYV6
RYAEAVQLLGGELQR	TTC30B	26	Q8N4P2
TLVIQQRGVRIYDGE	VPS36	16	Q86VN1
ILQRVREIRYQGGNR	VWF	1561	P04275
LEQRRQGLETYLQAV	SNX24	71	Q9Y343
LEDLQNRGVRYILNV	SSH2	326	Q76I76
IQNQRLYEIGGNIGE	ARHGAP28	686	Q9P2N2
LYQRQQERGGIIDLE	RNF25	241	Q96BH1
AAGYNRVRIVQLLLQ	TNKS	376	O95271
TLLQEYGLLQRRLEN	ZNF398	101	Q8TD17
QLHNGRVNYRELLLE	GPLD1	41	P80108
IIDLIYLNGLRNEGR	TTLL2	411	Q9BWV7
VILSLEQGNRLREQY	TP53BP1	1586	Q12888
RDGRVAQLEQVYIRG	SNRPD3	51	P62318
SRVIDRELYQQLQRG	PLEC	3126	Q15149
TRRRQYGEVANLLQG	VPS53	166	Q5VIR6
LEQRRQGLEAYIQGI	SNX22	76	Q96L94
LRVGLQRYLQGSSVQ	VASN	476	Q6EMK4
IRYRIVQLGGSNAQR	TTC38	401	Q5R3I4
VLGTLLQEYGLLQRR	ZNF212	96	Q9UDV6
LQEYGLLQRRLENVE	ZNF212	101	Q9UDV6
DYLGVRIQLRREQGA	PIEZO1	2381	Q92508
YFLLQILRRIGAVGQ	SUN1	221	O94901
VLGTLLQEYGLLQRR	ZNF746	66	Q6NUN9
LQEYGLLQRRLENVE	ZNF746	71	Q6NUN9
REQQVRLIYQGQLLG	TMUB1	136	Q9BVT8
GYIRTVLGQQILGQL	PKP2	11	Q99959
RGLQAQGYGVRIQDA	TNFSF13	146	O75888
TLLQEYGLLQRRLEN	ZNF282	156	Q9UDV7
TLLQEYGLLQRRLEN	ZNF783	101	Q6ZMS7
YGLLQRRLENVENLL	ZNF783	106	Q6ZMS7
ELQALRQYLGGRDSL	PDE4DIP	676	Q5VU43